Albert Labs

Curated by Signal

Developer of therapeutics for the treatment of mental health

Overview

Developer of therapeutics for the treatment of mental health. The company develops psychedelic-based medicines for the treatment of resistant depression, anxiety, drug addiction, and much more. The lead candidate of the company is KRN-101 to address cancer-related anxiety & depression.

Key facts

Founded: 2014
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Miracle Leaf
Online pharmacy for medical and recreational cannabis products
Health TechnologyGuildford, United Kingdom
CBD Pure Life
Online pharmacy for cannabis wellness and recreational products
Health TechnologyTiptree, United Kingdom
Atalis
Provider of a platform for industry data, intelligence, analytics, and insights for cannabis businesses
Health TechnologyLondon, United Kingdom

About Albert Labs

What does Albert Labs do?

Developer of therapeutics for the treatment of mental health.

Where is Albert Labs headquartered?

Albert Labs is headquartered in London, United Kingdom.

When was Albert Labs founded?

Albert Labs was founded in 2014.

Which sector is Albert Labs in?

Albert Labs operates in Health Technology.

Who are Albert Labs's competitors?

Companies similar to Albert Labs include Miracle Leaf, CBD Pure Life, and Atalis.